Aceso Life Science Group Limited (stock code: 00474) released its monthly return for equity securities as of 31 October 2025. The total authorized share capital remained at HKD 500,000,000, with 50,000,000,000 ordinary shares at HKD 0.01 each. No changes were recorded in the authorized or issued share capital during the reporting period.

The number of issued shares stayed at 7,381,776,805, with no treasury shares at both the beginning and end of the month. The return also confirmed that there were no share options, warrants, convertibles, or other agreements for issuing further shares. The submission was filed on 03 November 2025, with all relevant confirmations provided in accordance with applicable listing and regulatory requirements.